About EXACT Therapeutics
EXACT Therapeutics is a company based in Oslo (Norway) founded in 2012. The company has 7 employees as of December 31, 2021. EXACT Therapeutics offers products and services including ACT® Technology and Clinical Trials Services. EXACT Therapeutics operates in a competitive market with competitors including Lucerno Dynamics, Quality Electrodynamics, BioProtect, CareRay Digital Medical Systems and m2m Imaging Corp, among others.
- Headquarter Oslo, Norway
- Employees 7 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Exact Therapeutics As
-
Annual Revenue
$6.05 K (USD)0as on Dec 31, 2021
-
Net Profit
-$6.96 M (USD)-80as on Dec 31, 2021
-
EBITDA
-$6.81 M (USD)-81as on Dec 31, 2021
-
Latest Funding Round
$16.46 M (USD), Post-IPO
Jul 14, 2020
-
Investors
Canica
& 1 more
-
Employee Count
7
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EXACT Therapeutics
EXACT Therapeutics offers a comprehensive portfolio of products and services, including ACT® Technology and Clinical Trials Services.
Ultrasound system enhancing drug uptake in tumors for cancer treatment.
Platform for oncology trials focusing on pancreatic and CNS cancers.
People of EXACT Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of EXACT Therapeutics
Investors in EXACT Therapeutics
EXACT Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Canica and Sundt Construction.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canica is recognized as a privately owned investment company.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EXACT Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EXACT Therapeutics
Investment portfolio details for EXACT Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EXACT Therapeutics
Detailed financials for EXACT Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exact Therapeutics Comparisons
Peer comparison for EXACT Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EXACT Therapeutics
EXACT Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lucerno Dynamics, Quality Electrodynamics, BioProtect, CareRay Digital Medical Systems and m2m Imaging Corp., among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Imaging technology for radiotracer quality assessment is developed.
|
|
| Locked | Locked | Locked |
Magnetic resonance equipment and accessories for clinical diagnosis
|
|
| Locked | Locked | Locked |
Radiation protection technology is developed for prostate cancer radiotherapy.
|
|
| Locked | Locked | Locked |
Imaging X-Ray panel detectors for medical and industrial applications
|
|
| Locked | Locked | Locked |
Preclinical MRI Imaging Devices and Accessories
|
Detailed competitors of EXACT Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exact Therapeutics
Complete news archive for EXACT Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EXACT Therapeutics
EXACT Therapeutics was founded in 2012 and raised its 1st funding round 8 years after it was founded.
EXACT Therapeutics is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Masha Stromme is the current CEO of EXACT Therapeutics.
As of Dec 31, 2021, the latest employee count at EXACT Therapeutics is 7.
Annual revenue of EXACT Therapeutics is $6.05K as on Dec 31, 2021.
EXACT Therapeutics provides a sonoporation platform for the diagnosis of multiple diseases. The company offers its flagship technology platform Acoustic Cluster Therapy (ACT) for targeting therapeutic enhancement. It is used for the ultrasound for the diagnosis of oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The company is currently in Phase I of the clinical trial for a cancer diagnosis like for liver metastases, secondary to colorectalpancreatic cancer among others.
EXACT Therapeutics's top competitors include BioProtect, CQ Medical and Quality Electrodynamics.
EXACT Therapeutics offers ACT® Technology and Clinical Trials Services.
EXACT Therapeutics has 2 investors. Key investors include Canica, and Sundt Construction.